Clinical Electrophysiology (Heart Rhythm On demand ) 2022

$10.00

SKU: 3d177502971b Category: Tag:

Description

Description
A curated bundle of Clinical Electrophysiology sessions presented at Heart Rhythm 2022. The education is presented in various learning formats, including Case-Based, Case-Based: Complicated Case, Tutorial, Core Curriculum, Abstracts, and more. Please note: this bundle does not include credit.
Content Overview

The Clinical Electrophysiology category contains the following sessions from Heart Rhythm 2022:

  • #HRS2022 YIA Competition – Clinical EP Finalists (EN-571)
  • (Under-)Utilization of Anticoagulation for AF (CE-539)
  • Addressing the Needs of a Diverse Arrhythmia Population (JS-460)
  • Arrhythmias in the Community: Risk factors, Detection and Management (CE-544)
  • Arrhythmias Related to Spirochetes, Parasites and Viruses (CE-300)
  • Arriving at a Better Understanding of COVID-19 and Arrhythmias (CE-541)
  • Best of Heart Rhythm Case Reports (CE-585) Best of Heart Rhythm O2 (CE-726)
  • Board Review for EP Fellows: SVT and VT (CE-314)
  • Can Genetics Help After a Young Sudden Cardiac Death? (JS-193)
  • Cardio-oncology: New Cancer Therapeutics and Arrhythmias (CE-299)
  • Challenges and Updates in Arrhythmic Mitral Valve Prolapse Syndrome (CE-326)
  • Challenging Cases for the Electrophysiologist (PC-578)
  • Complex SVT Discrimination by Pacing Maneuvers (CE-223)
  • Conduction System Pacing? LBBB Area Pacing and Beyond (JS-404)
  • Controversies in Arrhythmia Management in Athletes (CE-207)
  • Controversies in Atrial Fibrillation and Lifestyle Management (CE-286)
  • Cutting Edge Advances and Challenges in Managing Patients with Arrhythmogenic Cardiomyopathy (JS-453)
  • Debate: Pill in the Pocket DOAC Guided By Long-Term Continuous Monitoring as a Strategy For Stroke Prevention in AF Patients: Myth or a Possibility (CE-487)
  • Debate: What is the Role of LAA Occlusion for Stroke Prevention in Atrial Fibrillation? (CE-303)
  • Does Sex Matter? (CE-507)
  • Early AF Treatment: Prime Time or Hold the Horses (JS-445)
  • Epicardial Mapping and Ablation in 2022 – State of the Art (JS-458)
  • Genotype-First Arrhythmia Risk Prediction for Arrhythmogenic Cardiomyopathy (ACM) – What Have We Achieved and Where are We Going? (JS-174)
  • Getting an Eye on the Target Before the Ablation of SVT (CE-542)
  • Global Arrhythmia Education and Continuous Quality Improvement (CQI) – It Takes a Planet, not a Village (JS-452)
  • Heart Rhythm Journal Presents: New Advances in Managing Cardiac Arrhythmias (CE-584)
  • How to Conquer the Difficult Procedure (CE-315)
  • How to Optimize Care for AF Patients in the Preablation Period (JS-451)
  • Inside Out: The Left Ventricle (CE-310)
  • Introduction of the New HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy: A Case-Based Discussion of Recommendations (CE-342)
  • Investigation of Decedents with Sudden Unexplained Death and Patients with Sudden Cardiac Arrest and of Their Families (JS-285)
  • Late-Breaking Clinical Trials: Clinical Innovations (LB-734)
  • Left Atrial Appendage Occlusion: Trials and Tribulations (CE-538)
  • Localization Insights from the Electrocardiogram (JS-459)
  • Looking Forward: What Ongoing Clinical Trials Could Teach Us (CA-509)
  • Making Genomics Equitable for All Patients with Heritable Cardiovascular Disease (JS-146) Management of the Asymptomatic Patient with a High Burden of PVCs (CE-307)
  • Managing Arrhythmic Risk: New Technologies and Techniques (CE-343)
  • New trials in VT management (CE-540) New Uses for Old Drugs (CE-432)
  • Novel Arrhythmia Insights and Mapping Techniques (CE-520)
  • Novel Mapping Approaches for Atrial Fibrillation (CE-100)
  • Opioids and Arrhythmia Risk (JS-426)
  • Optimal and Personalized Management of Atrial Fibrillation (JS-434)
  • Peri-TAVR Conduction Blocks: To Pace or Not to Pace (CE-302)
  • Pre-Excitation . . . and: Understanding Associated Conditions (CE-486)
  • Presenting the 2022 HRS Expert Consensus Statement on Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders: Development, Rationale, and Application (CE-410)
  • Racial and Ethnic Disparities in Clinical Electrophysiology (CE-124)
  • Radiation Safety For Eps (CE-485)
  • Sex Differences in Cardiac Arrhythmias (CE-245)
  • SVTs Mediated by Variant Accessory Pathways (CE-169)
  • The Early the Better: Afib Detection and Stroke (CE-543)
  • Translating Genetics to Optimize Arrhythmia Care (JS-338)
  • Understanding and manipulating the autonomic nervous system (CE-521)
  • Update on Dysautonomic Syndromes: Pacing, Neuroablation and COVID (CE-346)
  • Ventricular Tachycardia Management in Arrhythmic Syndromes (CE-175)
  • Ventricular Tachycardia: Prediction, Outcomes, and Treatment (CE-522)
Learning Objectives

After watching a reasonable amount of Clinical Electrophysiology (Heart Rhythm 2022), the learner should be able to:

  • Identify and analyze the latest scientific advances and innovations in the field of heart rhythm disorders.
  • Select appropriate, evidence-directed pharmacological and non-pharmacological therapies to achieve optimal outcomes for patients with heart rhythm disorders.
  • Recognize alternative perspectives regarding areas of controversy for which scientific evidence is insufficient, controversial, inconclusive, or confusing.
  • Utilize quality improvement measures, methods, and tools to foster systems-based improvements in heart rhythm care, outcome, and value.
  • Analyze and improve processes related to inter-professional teams, care coordination, patient engagement, and communication to optimize the delivery of patient- and family-centered care.
  • Assess the impact of regulatory and institutional policies, and societal and cultural norms, on safety, timeliness, equity (including diversity and inclusion), effectiveness, efficiency, patient-centered care, and value.
  • Utilize improved communication methods to engage with patients and caregivers for increased shared decision-making in the treatment of heart rhythm disorders
  • Evaluate the latest technology available for both professionals and consumers in the field of heart rhythm disorders.
  • Recognize disparities in health care and describe strategies to reduce these disparities in patient care.
  • Utilize shared decision-making resources in discussing monitoring and treatment of patients with heart rhythm disorders.
  • Describe the latest cardiac device advisories and/or recalls and explain how to share this information with patients and caregivers.
  • Explain the current and future trends in digital health that will impact the treatment of heart rhythm disorders.
  • Describe best practices for managing a device clinic, an AF center, and/or a multidisciplinary electrophysiology practice